Sabra Health Care REIT (SBRA) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, to elect seven directors, ratify PwC as auditor, and approve executive compensation on an advisory basis.

• Board and management emphasize long-term value creation, disciplined growth, and a strong balance sheet.

• Proxy materials and annual report are available online, with multiple voting methods offered.

Voting matters and shareholder proposals

• Proposals include election of seven directors, ratification of PwC as auditor for 2026, and advisory approval of executive compensation.

• Board recommends voting FOR all proposals.

• Majority voting standard applies for director elections; advisory votes are non-binding but considered by the Board.

• Shareholders can submit proposals and director nominations for the 2027 meeting, with clear deadlines and requirements.

Board of directors and corporate governance

• Board consists of seven members, six of whom are independent; all standing committees are fully independent.

• Board diversity: 43% gender diverse, 14% racial/ethnic diversity.

• Annual election of directors, majority voting, no supermajority requirements, and robust stock ownership policies.

• Proxy access allows significant shareholders to nominate directors.

• Lead Independent Director role established; regular executive sessions held.

• Annual board and committee evaluations and proactive succession planning.